DOTA-CA-170

• Description:

  DOTA-CA-170 is a DOTA-modified VISTA targeting agent CA-170. DOTA-CA-170 can be radiolabeled. DOTA-CA-170 can be used in the research of visualizing and distinguishing VISTA expression[1].

• UNSPSC:

  12352209

• Target:

  Radionuclide-Drug Conjugates (RDCs) ; VISTA

• Related Pathways:

  Antibody-drug Conjugate/ADC Related

• Field of Research:

  Cancer

• Smiles:

  C[C@@H](O)[C@@H](C(O)=O)NC(N[C@H](C1=NC([C@@H](NC(CN2CCN(CCN(CCN(CC2)CC(O)=O)CC(O)=O)CC(O)=O)=O)CO)=NO1)CC(N)=O)=O

• Molecular Formula:

  C28H46N10O14

• Molecular Weight:

  746.72

• References & Citations:

  [1]Liu J, et al. Small-Molecule Radiotracers for Visualization of V-Domain Immunoglobulin Suppressor of T Cell Activation. J Med Chem. 2024 Oct 10;67 (19) :17690-17700.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Peptides

• Clinical Information:

  No Development Reported